| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/26/2001 | CN1071572C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 09/25/2001 | US6294669 As antibiotic prodrug; for oral administration |
| 09/25/2001 | US6294668 Antibacterial activity against beta-lactam sensitive and resistant gram-positive bacteria, such as staphylococci, pneumococci, and enterococci; used in therapy of infectious diseases caused by those bacteria |
| 09/25/2001 | US6294652 Response regulator |
| 09/25/2001 | US6294572 Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
| 09/25/2001 | US6294565 Treatment of leukemia by administering a bisimidazole thiophene |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294550 Treatment of female sexual dysfunction |
| 09/25/2001 | US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 09/25/2001 | US6294529 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 09/25/2001 | US6294528 Antibiotics as bactericides |
| 09/25/2001 | US6294527 Antibiotics for methacillin resistant bacteria |
| 09/25/2001 | US6294378 Method and reagents for genetic immunization |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | US6294322 Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
| 09/25/2001 | US6294199 The dosage is provided by a bilayer tablet. |
| 09/25/2001 | US6294186 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 09/25/2001 | US6294177 Particularly useful in the treatment of mastitis. |
| 09/25/2001 | US6294176 Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
| 09/25/2001 | US6294175 Compounds |
| 09/25/2001 | US6294174 Peptides immunologically related to known viral protein |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | US6294168 Selectively binding said haloperoxidase to the pathogenic microbes, |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/25/2001 | CA2059999C Process for preparing 2'-(diethylamino)rifamycin p (p/dea) |
| 09/20/2001 | WO2001068903A1 Modulating production of pneumococcal capsular polysaccharide |
| 09/20/2001 | WO2001068865A2 Fish vaccine against piscirickettsia salmonis |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068820A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/20/2001 | WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068663A1 Nucleoside compounds and uses thereof |
| 09/20/2001 | WO2001068662A1 Method of preparing clarithromycin of form ii crystals |
| 09/20/2001 | WO2001068647A1 Medicaments against viral diseases |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068642A1 Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 09/20/2001 | WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases |
| 09/20/2001 | WO2001068640A1 Medicaments against viral diseases |
| 09/20/2001 | WO2001068639A1 Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases |
| 09/20/2001 | WO2001068607A1 Amide compounds and use thereof |
| 09/20/2001 | WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 09/20/2001 | WO2001068591A1 Carboxylic acid derivatives as ip antagonists |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068144A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068143A2 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068142A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 09/20/2001 | WO2001068129A2 Adjuvant for vaccines |
| 09/20/2001 | WO2001068128A1 Pneumococcus polysaccharide conjugates for use as vaccine against tetanus and diphtheria |
| 09/20/2001 | WO2001068122A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 09/20/2001 | WO2001068117A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | WO2001068116A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 09/20/2001 | WO2001068103A2 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
| 09/20/2001 | WO2001068102A2 Nystatin formulation having reduced toxicity |
| 09/20/2001 | WO2001068091A1 Inhibition of fungi |
| 09/20/2001 | WO2001068090A1 Microbial inhibitory compositions |
| 09/20/2001 | WO2001068086A1 Antiviral therapy |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068078A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | WO2001068077A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | WO2001068058A1 Multilayer pharmaceutical product for release in the colon |
| 09/20/2001 | WO2001068055A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 09/20/2001 | WO2001068034A2 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001041567A8 Deep penetrating antimicrobial compositions |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 09/20/2001 | WO2001019850A3 Nrage nucleic acids and polypeptides and uses thereof |
| 09/20/2001 | WO2001019819A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016603A3 Analysis and treatment of body weight and eating disorders |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001013942A3 Trehalose producing prokaryotic cells as vaccines |
| 09/20/2001 | WO2001012223A3 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 09/20/2001 | WO2001010456A3 Peptides that block viral infectivity and methods of use thereof |
| 09/20/2001 | WO2001010427A3 Use of anti-muscarinic agents for treating skin disorders |
| 09/20/2001 | WO2001008702A9 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 09/20/2001 | WO2000053577A9 Hydrazide inhibitors of hiv-1 integrase |
| 09/20/2001 | WO2000047583A9 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 09/20/2001 | WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | US20010023292 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
| 09/20/2001 | US20010023291 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 09/20/2001 | US20010023256 Reducing concentration of oxygen metabolites |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | US20010022969 Sepsis therapy |
| 09/20/2001 | US20010022964 Fast dissolving orally consumable films |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | DE10013125A1 New 4-dihalophenyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | DE10013029A1 Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively |
| 09/20/2001 | DE10012824A1 New 6-hydroxyhydrocarbyl or 6-thiohydrocarbyl-dihydropyrimidine-5-carboxylic acid derivatives, useful for the treatment of viral infections, especially hepatitis B infections |
| 09/20/2001 | DE10012823A1 New alkyl-6-aminoalkyl-dihydropyrimidine-5-carboxylate derivatives, useful for the treatment of viral, especially hepatitis B, infections |